TCAF - ETF AI Analysis
Top Page
T. Rowe Price Capital Appreciation Equity ETF (TCAF)
Rating:71Outperform
Price Target:―
Positive Factors
Large, Established Top Holdings
The ETF’s biggest positions are in well-known, mega-cap companies that tend to be more stable and widely followed by investors.
Broad Sector Diversification
Holdings spread across technology, health care, consumer, financials, utilities, and other sectors help reduce the impact of weakness in any single industry.
Significant Fund Size
The ETF manages a large pool of assets, which can support better liquidity and trading efficiency for investors.
Negative Factors
Recent Weak Performance
The fund has shown negative returns over the past month, three months, and year-to-date, indicating recent performance has been soft.
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the ETF offers very limited geographic diversification outside the United States.
Tech-Heavy Portfolio
A large tilt toward technology stocks means the fund may be more sensitive to downturns or volatility in the tech sector.
TCAF vs. SPDR S&P 500 ETF (SPY)
AUM6.26B
RegionNorth America
Expense Ratio0.31%
Beta0.88
IssuerT. Rowe Price
Inception DateJun 14, 2023
Dividend Yield0.53%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,124,305
30 Day Avg. Volume962,033
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
50.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering91
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TCAF Summary
T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an actively managed fund that focuses on large U.S. companies, rather than tracking a set index. It aims for long-term growth by investing in many well-known names such as Microsoft, Apple, Nvidia, Amazon, and Alphabet, with a heavy tilt toward technology and health care. Investors might consider TCAF for broad exposure to leading, established businesses in one simple investment, which can help with diversification and growth potential over time. A key risk is that it is heavily exposed to big tech and stock prices can go up and down with the overall market.
How much will it cost me?The TCAF ETF has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, meaning professional managers select stocks rather than following a preset index. Active management often leads to higher costs due to research and decision-making efforts.
What would affect this ETF?The TCAF ETF, with its strong focus on large-cap U.S. companies, could benefit from continued growth in the technology sector, which makes up a significant portion of its holdings, especially with major players like Microsoft, Nvidia, and Apple leading innovation. However, it may face challenges if interest rates rise, as this could pressure valuations in growth-oriented sectors like tech and consumer cyclical, or if regulatory changes impact large-cap companies. Economic conditions in the U.S., such as inflation or recession risks, could also influence the ETF's performance positively or negatively.
TCAF Top 10 Holdings
TCAF is leaning heavily on U.S. mega-cap tech, with Microsoft, Amazon, Apple, Nvidia, Alphabet, and Meta forming the core engine—but lately that engine has been sputtering. Most of these Big Tech names have been lagging, as rich valuations and softer technical trends take some shine off their long-term growth stories. Balancing that, steady utilities like CenterPoint Energy and Nisource have quietly held up better, acting as defensive ballast. Overall, the fund is both sector- and name-concentrated in U.S. technology, so its fortunes still rise and fall with Big Tech’s mood swings.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Microsoft | 7.17% | $440.03M | $2.77T | 3.78% | 79 Outperform | |
| Amazon | 6.37% | $390.73M | $2.25T | 22.67% | 71 Outperform | |
| Apple | 5.90% | $362.15M | $3.76T | 35.85% | 79 Outperform | |
| Nvidia | 5.36% | $329.12M | $4.31T | 88.09% | 76 Outperform | |
| Alphabet Class A | 4.09% | $251.09M | $3.57T | 103.14% | 85 Outperform | |
| Meta Platforms | 4.01% | $246.25M | $1.45T | 13.82% | 76 Outperform | |
| Centerpoint Energy | 3.33% | $204.39M | $28.54B | 21.15% | 63 Neutral | |
| Broadcom | 3.17% | $194.47M | $1.49T | 115.02% | 76 Outperform | |
| Nisource | 3.12% | $191.58M | $22.73B | 27.59% | 64 Neutral | |
| Keurig Dr Pepper | 2.41% | $147.81M | $34.39B | -25.14% | 71 Outperform |
TCAF Technical Analysis
Negative
―
Price Trends
37.09
Negative
37.65
Negative
37.17
Negative
Market Momentum
-0.53
Negative
45.69
Neutral
72.58
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TCAF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 36.07, equal to the 50-day MA of 37.09, and equal to the 200-day MA of 37.17, indicating a bearish trend. The MACD of -0.53 indicates Negative momentum. The RSI at 45.69 is Neutral, neither overbought nor oversold. The STOCH value of 72.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TCAF.
TCAF Peer Comparison
Comparison Results
Performance Comparison
TCAF
T. Rowe Price Capital Appreciation Equity ETF
35.89
6.58
22.45%
QQQI
NEOS Nasdaq 100 High Income ETF
―
―
―
SPYI
NEOS S&P 500 High Income ETF
―
―
―
DIVO
Amplify CWP Enhanced Dividend Income ETF
―
―
―
FELC
Fidelity Enhanced Large Cap Core ETF
―
―
―
GRNY
Fundstrat Granny Shots US Large Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents